Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05110196` - Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.	Phase 4
Completed	`NCT02795156` - Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations	Phase 2
Terminated	`NCT02556593` - IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases	Phase 2
Active, not recruiting	`NCT03678350` - Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery	Phase 1
Recruiting	`NCT05358249` - Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation	Phase 1/Phase 2
Recruiting	`NCT02273271` - Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo	N/A
Withdrawn	`NCT03408561` - Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer	N/A
Active, not recruiting	`NCT04984811` - NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC	Phase 2
Completed	`NCT02922777` - Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.	Phase 1
Active, not recruiting	`NCT01279408` - Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)
Completed	`NCT00081315` - Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer	Phase 2
Active, not recruiting	`NCT03731585` - Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment	N/A
Active, not recruiting	`NCT02009449` - A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors	Phase 1
Completed	`NCT03849469` - A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors	Phase 1
Completed	`NCT02848872` - Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer
Not yet recruiting	`NCT06222489` - Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT	Phase 2
Active, not recruiting	`NCT03752398` - A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)	Phase 1
Terminated	`NCT01288430` - A Study of DS-2248 in Participants With Advanced Solid Tumors	Phase 1
Recruiting	`NCT05642195` - Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer	Phase 1/Phase 2
Completed	`NCT02394548` - Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer	N/A

NCT number	NCT00540514
Study type	Interventional
Source	Celgene
Contact
Status	Completed
Phase	Phase 3
Start date	November 1, 2007
Completion date	February 1, 2013

Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms